IL142442A0 - BENZOTHIENO [3,2-C] PYRIDINES AS α2 ANTAGONISTS - Google Patents

BENZOTHIENO [3,2-C] PYRIDINES AS α2 ANTAGONISTS

Info

Publication number
IL142442A0
IL142442A0 IL14244299A IL14244299A IL142442A0 IL 142442 A0 IL142442 A0 IL 142442A0 IL 14244299 A IL14244299 A IL 14244299A IL 14244299 A IL14244299 A IL 14244299A IL 142442 A0 IL142442 A0 IL 142442A0
Authority
IL
Israel
Prior art keywords
benzothieno
pyridines
antagonists
Prior art date
Application number
IL14244299A
Other languages
English (en)
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IL142442A0 publication Critical patent/IL142442A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL14244299A 1998-10-06 1999-10-01 BENZOTHIENO [3,2-C] PYRIDINES AS α2 ANTAGONISTS IL142442A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98203363 1998-10-06
PCT/EP1999/007418 WO2000020422A1 (en) 1998-10-06 1999-10-01 BENZOTHIENO[3,2-c]PYRIDINES AS α2 ANTAGONISTS

Publications (1)

Publication Number Publication Date
IL142442A0 true IL142442A0 (en) 2002-03-10

Family

ID=8234188

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14244299A IL142442A0 (en) 1998-10-06 1999-10-01 BENZOTHIENO [3,2-C] PYRIDINES AS α2 ANTAGONISTS
IL142442A IL142442A (en) 1998-10-06 2001-04-04 Benzothiano [C – 2,3] pyridines as antagonists of type a2

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL142442A IL142442A (en) 1998-10-06 2001-04-04 Benzothiano [C – 2,3] pyridines as antagonists of type a2

Country Status (28)

Country Link
US (2) US6426350B1 (zh)
EP (1) EP1117667B1 (zh)
JP (1) JP4580555B2 (zh)
KR (1) KR20010071828A (zh)
CN (1) CN1158287C (zh)
AR (1) AR023678A1 (zh)
AT (1) ATE363485T1 (zh)
AU (1) AU760226B2 (zh)
BG (1) BG64625B1 (zh)
BR (1) BR9913110A (zh)
CA (1) CA2346084C (zh)
CZ (1) CZ20011103A3 (zh)
DE (1) DE69936219T2 (zh)
EE (1) EE04835B1 (zh)
ES (1) ES2288025T3 (zh)
HK (1) HK1039113A1 (zh)
HU (1) HUP0103612A3 (zh)
ID (1) ID28280A (zh)
IL (2) IL142442A0 (zh)
NO (1) NO20011309L (zh)
NZ (1) NZ509911A (zh)
PL (1) PL347184A1 (zh)
RU (1) RU2222542C2 (zh)
SK (1) SK4312001A3 (zh)
TR (1) TR200100954T2 (zh)
TW (1) TWI251595B (zh)
UA (1) UA70334C2 (zh)
WO (1) WO2000020422A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE494000T1 (de) * 2002-03-08 2011-01-15 Max Planck Gesellschaft Verwendung von egfr transaktivierungsinhibitoren für menschlichen krebs
CA2480266C (en) * 2002-04-03 2011-07-12 Orion Corporation Use of an alpha2-adrenoreceptor antagonist for cns-related diseases
EP1757605A4 (en) 2004-04-12 2007-12-19 Taisho Pharmaceutical Co Ltd CYCLIC AMINE COMPOUND

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3752820A (en) * 1972-03-20 1973-08-14 Colgate Palmolive Co Substituted-1,2,3,4-tetrahydrobenzothieno(3,2-c)pyridine derivatives
FR2570701B1 (fr) * 1984-09-27 1987-05-22 Synthelabo Derives de furo(3,2-c)pyridines, leur preparation et leur application en therapeutique
US4686226A (en) * 1985-09-03 1987-08-11 Merck & Co., Inc. Substituted benzo[b]furo- and benzo[b]thieno quinolizines
EP0339959A3 (en) * 1988-04-27 1991-03-20 Glaxo Group Limited Lactam derivatives
US5100891A (en) * 1991-01-18 1992-03-31 Hoechst-Roussel Pharmaceuticals Inc. Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds
ATE247114T1 (de) * 1994-09-12 2003-08-15 Lilly Co Eli Serotonergische modulatoren
JP3274579B2 (ja) * 1995-01-12 2002-04-15 住友製薬株式会社 脳血管障害に伴う精神症候治療剤
UA52681C2 (uk) * 1997-04-08 2003-01-15 Янссен Фармацевтика Н.В. Похідні 1,2,3,4-тетрагідро-бензофуро[3,2,-c]піридину, спосіб їх одержання та фармацевтична композиція на їх основі

Also Published As

Publication number Publication date
DE69936219D1 (de) 2007-07-12
JP4580555B2 (ja) 2010-11-17
PL347184A1 (en) 2002-03-25
BG105331A (en) 2001-11-30
UA70334C2 (en) 2004-10-15
SK4312001A3 (en) 2001-12-03
AU760226B2 (en) 2003-05-08
CA2346084A1 (en) 2000-04-13
TR200100954T2 (tr) 2001-12-21
ID28280A (id) 2001-05-10
EP1117667B1 (en) 2007-05-30
WO2000020422A1 (en) 2000-04-13
US6426350B1 (en) 2002-07-30
HK1039113A1 (en) 2002-04-12
CZ20011103A3 (cs) 2001-12-12
IL142442A (en) 2006-10-05
EE04835B1 (et) 2007-06-15
EP1117667A1 (en) 2001-07-25
HUP0103612A3 (en) 2003-03-28
ATE363485T1 (de) 2007-06-15
KR20010071828A (ko) 2001-07-31
DE69936219T2 (de) 2008-02-07
NZ509911A (en) 2002-09-27
EE200100206A (et) 2002-06-17
US20020169178A1 (en) 2002-11-14
TWI251595B (en) 2006-03-21
CN1321159A (zh) 2001-11-07
ES2288025T3 (es) 2007-12-16
HUP0103612A2 (hu) 2002-01-28
AR023678A1 (es) 2002-09-04
RU2222542C2 (ru) 2004-01-27
NO20011309D0 (no) 2001-03-15
CA2346084C (en) 2010-01-26
CN1158287C (zh) 2004-07-21
JP2002526546A (ja) 2002-08-20
BG64625B1 (bg) 2005-09-30
US6774129B2 (en) 2004-08-10
BR9913110A (pt) 2001-05-08
NO20011309L (no) 2001-03-15
AU6089999A (en) 2000-04-26

Similar Documents

Publication Publication Date Title
IL157873A0 (en) DIHYDRO-BENZO [b] [1,4] DIAZEPIN-2-ONE DERIVATIVES AS MGLUR2 ANTAGONISTS II
AU6751301A (en) 1,3,8-triaza-spiro'4,5]decan-4-one derivatives as neurokinin receptor antagonists
HUP9700885A3 (en) Novel process for producing thieno[3,2-c]pyridine derivatives
AP9701077A0 (en) Substituted 6,5-hetero bicyclic derivatives
AP9701076A0 (en) Substituted 6,6-hetero bicyclic derivatives
PL367086A1 (en) Dihydro-benzo[b][1,4]diazepin-2-one derivatives as mglur2 antagonists i
ZA98570B (en) 8-substituted-1,3,8-triaza-spiro[4,5]decan-4-on derivatives
HUP0202202A3 (en) Benzoxepino [2,3-b]pyridine derivatives and analogues as chemokine receptor antagonists and the use thereof
IL140249A0 (en) Muscarinic antagonists
IL142045A0 (en) Naphthalenecarboxamides as tachykinin receptor antagonists
HU9901911D0 (en) Diaza-spiro[3,5]nanone derivatives
PL332382A1 (en) Derivatives of 1,2,3,4-tetrahydro-benzofuro [3,2-c] pyridine
IL135982A0 (en) Fungicidal combinations comprising thieno[2,3-d]pyrimidin-4-one
PL347493A1 (en) Fungicidal combinations comprising thieno[2,3-d]pyrimidin-4-one
IL138220A0 (en) 3',3',-n-bis substituted macrolide lhrh antagonists
IL129660A0 (en) Piperazino derivatives as neurokinin antagonists
ID23283A (id) SPIRO [PIPERIDINA-4,1'-PIROLO (3,4-c) PIROLO]
IL142442A0 (en) BENZOTHIENO [3,2-C] PYRIDINES AS α2 ANTAGONISTS
PL356668A1 (en) Novel substituted pyrazolo[4,3-e
ZA991411B (en) Substituted imidazo [1,2-A:3,4A']diquinolinylium interleukin-8 receptor antagonist.
GB9616467D0 (en) Pyrrolo[3,2-c]quinoline derivatives
AU5112699A (en) 5-HT1f antagonists
IL142362A0 (en) Ureidopiperidine derivatives as selective human nk3 receptor antagonists
IL155380A0 (en) SUBSTITUTED 3,4-DIHYDRO-PYRIDO[1,2-a] PYRIMIDINES
PL325356A1 (en) Novel derivative 2,4-dioxo-1,2,3,4-tetrahydropyrido[2,3-d]pyrimidin-5-carboxylic pyrolydinamide

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed